咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >A portable pneumatic compressi... 收藏

A portable pneumatic compression device to prevent venous thromboembolism in orthopedic patients with the highest risks of both venous thrombosis and bleeding: A case series study

作     者:Takahashi, Yoshiki Takahira, Naonobu Shibuya, Manaka Uchiyama, Katsufumi Fukushima, Kensuke Iwase, Dai Kawamura, Tadashi Miyagi, Masayuki Higashiyama, Reiji Moriya, Mitsutoshi Sakai, Kenta Tsuda, Kouji Sakamoto, Miki Akamine, Akihiko Takaso, Masashi 

作者机构:Kitasato Univ Grad Sch Med Sci Sensory & Motor Control Minami Ku Sagamihara 1-15-1 Kitasato Sagamihara Kanagawa Japan Kitasato Univ Sch Allied Hlth Sci Dept Rehabil Minami Ku 1-15-1 Kitasato Sagamihara Kanagawa Japan Kitasato Univ Hosp Dept Rehabil Minami Ku 1-15-1 Kitasato Sagamihara Kanagawa Japan Kitasato Univ Sch Med Dept Orthopaed Surg Minami Ku 1-15-1 Kitasato Sagamihara Kanagawa Japan Kitasato Univ Hosp Dept Pharm Minami Ku Sagamihara Kanagawa Japan 

出 版 物:《JOURNAL OF ORTHOPAEDIC SURGERY》 (J. Orthop. Surg.)

年 卷 期:2020年第28卷第1期

核心收录:

基  金:Japan Society for the Promotion of Science (JSPS) [JP17K10940] 

主  题:ActiveCare plus S F T deep vein thrombosis hemorrhagic adverse events high risk of both venous thrombosis and bleeding portable intermittent pneumatic compression device prophylaxis venous thromboembolism wearing compliance 

摘      要:Purpose: There is a pressing need for safe venous thromboembolism (VTE) prophylaxis in orthopedic patients with the highest risks of both venous thrombosis and bleeding. Portable intermittent pneumatic compression device (IPCD) has proven to be effective and safe in patients with a high risk of venous thrombosis and low bleeding risk. Therefore, this study examined the effectiveness, safety, and wearing compliance of portable IPCD for postoperative VTE prophylaxis in patients with the highest risks of both venous thrombosis and bleeding. Methods: The cases consisted of 38 patients who had used a portable IPCD and had the highest risks of both venous thrombosis and bleeding. We examined the incidence of VTE to assess the effectiveness of the portable IPCD, the presence of hemorrhagic adverse events to assess safety, and the wearing rate to assess wearing compliance. Results: The incidences of asymptomatic and symptomatic deep vein thrombosis were 5.3% and 2.6%, respectively. The incidence of hemorrhagic adverse events was 21.1% in patients who received anticoagulants and wore an IPCD simultaneously and 0% in patients who wore an IPCD but did not receive anticoagulants. The wearing rate (i.e. = 18 h/day) was 100%. Conclusion: Portable IPCD has the potential for safe VTE prophylaxis in patients at high risks for both venous thrombosis and bleeding. Therefore, we suggest that such patients use a portable IPCD for VTE prophylaxis.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分